FWP IP APS has a total of 41 patent applications. It increased the IP activity by 225.0%. Its first patent ever was published in 2005. It filed its patents most often in United States, EPO (European Patent Office) and Israel. Its main competitors in its focus markets pharmaceuticals are SKINTECH LIFE SCIENCE LTD, BEIJING WEILANZHIYUAN MEDICAL TECH CO LTD and IMMUNO RX INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 17 | |
#2 | EPO (European Patent Office) | 6 | |
#3 | Israel | 4 | |
#4 | Japan | 4 | |
#5 | Australia | 3 | |
#6 | Canada | 1 | |
#7 | China | 1 | |
#8 | Hong Kong | 1 | |
#9 | Hungary | 1 | |
#10 | Republic of Korea | 1 | |
#11 | Luxembourg | 1 | |
#12 | Serbia | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Rupp Roland | 19 |
#2 | Andersen Peder M | 17 |
#3 | Nilsson Henrik | 16 |
#4 | Rundfeldt Chris | 10 |
#5 | Mueller Bernd W | 10 |
#6 | Robinson Joseph R | 10 |
#7 | Galetzka Christin | 10 |
#8 | Terwey Theis | 8 |
#9 | Schoenharting Florian | 7 |
#10 | Müller Bernd W | 3 |
Publication | Filing date | Title |
---|---|---|
JP2020037581A | Combination therapy for treating multiple sclerosis | |
HK1252751A1 | Pharmaceutical formulation comprising one or more fumaric acid esters in an erosion matrix | |
IL243660D0 | Pharmaceutical composition containing dimethyl fumarate for administration at a low daily dose | |
CN109453133A | For with the pharmaceutical composition containing dimethyl fumarate of low daily dose application |